• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
ABMD

ABMD

Abiomed, Inc.

NASDAQHealthcareMedical - DevicesUS

USD381.02

+0.00 (+0.00%)

Company Profile

CEO

Michael Minogue

IPO Date

1987-07-29

Sector

Healthcare

Industry

Medical - Devices

Exchange

NASDAQ

Country

US

Market Metrics

Open

$380.78

Prev. Close

$381.02

Day Low

$380.55

Day High

$381.28

52W Low

$219.84

52W High

$381.99

Market Cap

$17.18B

Volume

15.70M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

62.6%

Avg Negative

15.4%

Avg Neutral

22.2%

News Feed

Abiomed (ABMD) Reports Next Week: Wall Street Expects Earnings Growth

Zacks Investment Research·7/29/2021·↑ positive

Abiomed: Recovery Mode Has Been Activated - Reiterate Buy Rating

Seeking Alpha·7/13/2021·↑ positive

Could This Recently IPOed Medical Device Maker Make You Rich?

The Motley Fool·7/3/2021·↑ positive

Abiomed's (ABMD) Impella RP With SmartAssist Gets FDA Nod

Zacks Investment Research·6/30/2021·↑ positive

FDA Grants Highest Level of Approval to the Next Generation of Impella RP to Treat Right Heart Failure

Business Wire·6/29/2021·↑ positive

Abiomed (ABMD) Enters Overbought Territory

Zacks Investment Research·6/22/2021·↓ negative

Abiomed's (ABMD) preCARDIA Buyout Expands Its Product Portfolio

Zacks Investment Research·6/3/2021·↑ positive

Abiomed Acquires preCARDIA, a Breakthrough Medical Device Company, to Improve Outcomes for Heart Failure Patients

Business Wire·6/1/2021·↑ positive

Abiomed to Shareholders: Patience Please, Growth Is On The Way.

The Motley Fool·5/4/2021·↓ negative

ABIOMED (ABMD) Earnings and Revenues Beat Estimates in Q4

Zacks Investment Research·4/29/2021·↑ positive